investment

Live Nation Stock Sinks After Jury Finds It Operated As A Monopoly

PAOLO CONFINO

2 min read

0 likes

⚡ Quantum Brief

A Manhattan jury ruled that Live Nation Entertainment operated as a monopoly in live event ticket sales, triggering a 6.3% stock decline on Wednesday before a slight recovery Thursday. The U.S. Justice Department and state attorneys general led the civil antitrust case, alleging the company stifled competition in ticketing and event promotion. The proposed settlement, pending court approval, aims to ease barriers for rival promoters seeking venue access, potentially reshaping the live entertainment industry’s competitive landscape. Live Nation’s dominance stems from its 2010 merger with Ticketmaster, which critics argue created an unchecked market stronghold in ticket distribution and pricing. The ruling could force structural changes, including divestitures or operational restrictions, though Live Nation may appeal, prolonging legal uncertainty for investors and competitors.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

BREAKING: Market Keeps Rising; Netflix Dives LateLive Nation Entertainment (LYV) shares sank after a Manhattan jury found the entertainment juggernaut had operated as a monopoly in ticket sales for live events. On Wednesday, the stock closed down 6.3%, according to MarketSurge. Shares fell briefly in premarket trading on Thursday, before recovering to a fractional gain.

The Justice Department and several state attorneys general brought the civil… 3/09/2026 The settlement, which requires court approval, would make it easier for other promoters to compete for business at event locations... 3/09/2026 The settlement, which requires court approval, would make it easier... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!Get market updates, educational videos, webinars, and stock analysis.Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or performance. Authors/presenters may own the stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any specific investment strategies. Information is subject to change without notice. For information on use of our services, please see our Terms of Use.*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet.IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.©2026 Investor’s Business Daily, LLC.

Read Original

Source Information

Source: Investor's Business Daily

Website: https://www.investors.com/feed/

Discussion

0 professional contributions

Be the first to add a constructive contribution.